Medicare Enrolled
Dr. Carol Trakimas, D.O.
Dermatology · Goldsboro, NC
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Trakimas from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Trakimas?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Trakimas
Dr. Carol Trakimas is a dermatology specialist in Goldsboro, NC, with 19 years of NPI registration. Based on federal Medicare data, Dr. Trakimas performed 2,456 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Trakimas received a total of $10,847 from 41 pharmaceutical and/or device companies across 496 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Trakimas is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years of NPI registration
▲ 2,456 Medicare services
$10,847 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗2,456
Medicare services
Bottom 49% in NC for dermatology
Not available
Unique patients (not deduplicated)
$38
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Destruction of precancerous skin growths, 2-14 This procedure involves the removal or destruction of two to fourteen precancerous skin lesions. It is performed to eliminate abnormal skin cells that have the potential to develop into cancer. |
967 | $5 | $84 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
408 | $58 | $263 |
| Destruction of precancerous skin growth, 1 Removal of a single precancerous skin growth. This procedure destroys abnormal skin cells to prevent them from developing into cancer. |
218 | $31 | $304 |
| Destruction of skin growths (warts/lesions), 1-14 This procedure involves the removal or destruction of one to fourteen skin growths. It is a minor surgical intervention performed on the skin surface. |
176 | $78 | $419 |
| Skin biopsy, tangential A procedure to remove a sample of the first identified skin growth for laboratory examination. |
140 | $58 | $378 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
92 | $1 | $16 |
| Destruction of 15 or more precancerous skin growths This procedure involves the removal or destruction of fifteen or more precancerous skin lesions. It is performed to treat abnormal skin cells that have the potential to develop into cancer. |
84 | $115 | $734 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
84 | $34 | $148 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
68 | $62 | $321 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
48 | $9 | $72 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
47 | $85 | $372 |
| Topical aminolevulinic acid HCl 20% solution A topical medication applied to the skin for medical treatment. It is supplied as a single-unit dosage form containing 354 mg of the active ingredient. |
34 | $304 | $465 |
| Light therapy to destroy precancerous skin growth This procedure uses light to treat and remove precancerous skin lesions. It is a method for destroying abnormal skin cells before they become cancerous. |
29 | $98 | $495 |
| Additional skin growth biopsy Removal of a sample of an additional skin growth for laboratory examination. This code is used for each extra lesion biopsied during the same session. |
28 | $36 | $205 |
| New patient office visit, 15-29 minutes An initial office visit for a new patient lasting 15 to 29 minutes. This code is used when the total time spent on the date of the encounter meets this duration threshold. |
22 | $49 | $223 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
11 | $8 | $33 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$10,847
Total received (2018-2024)
Avg $1,550/year across 7 years
Top 16% in NC for dermatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
41
Companies
496
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,683
2023
$2,484
2022
$2,913
2021
$1,190
2020
$343
2019
$736
2018
$497
Payments by company (2024)
ABBVIE INC.
$624
Novartis Pharmaceuticals Corporation
$243
E.R. Squibb & Sons, L.L.C.
$242
LEO Pharma Inc.
$198
SUN PHARMACEUTICAL INDUSTRIES INC.
$185
GENZYME CORPORATION
$167
MERZ NORTH AMERICA, INC.
$164
Janssen Biotech, Inc.
$160
Amgen Inc.
$136
Galderma Laboratories, L.P.
$91
Incyte Corporation
$76
PFIZER INC.
$72
Lilly USA, LLC
$69
Dermavant Sciences, Inc.
$64
Boehringer Ingelheim Pharmaceuticals, Inc.
$54
Ortho Dermatologics, a division of Bausch Health US, LLC
$47
UCB, Inc.
$31
Verrica Pharmaceuticals Inc.
$24
Regeneron Healthcare Solutions, Inc.
$23
Genentech USA, Inc.
$16
Top 3 companies account for 41.3% of 2024 payments
All-time payments by company (2018-2024) ›
ABBVIE INC.
$1,262
AbbVie Inc.
$796
Novartis Pharmaceuticals Corporation
$703
Sun Pharmaceutical Industries Inc.
$637
GENZYME CORPORATION
$604
Janssen Biotech, Inc.
$579
Merz North America, Inc.
$526
PFIZER INC.
$491
Galderma Laboratories, L.P.
$467
LEO Pharma Inc.
$416
Almirall LLC
$399
SUN PHARMACEUTICAL INDUSTRIES INC.
$384
E.R. Squibb & Sons, L.L.C.
$327
Regeneron Healthcare Solutions, Inc.
$312
Journey Medical Corporation
$272
Lilly USA, LLC
$245
Amgen Inc.
$238
UCB, Inc.
$220
AbbVie, Inc.
$207
Dermavant Sciences, Inc.
$206
Celgene Corporation
$189
Ortho Dermatologics, a division of Bausch Health US, LLC
$173
MERZ NORTH AMERICA, INC.
$164
EPI Health, LLC
$150
Incyte Corporation
$147
Allergan Inc.
$117
PruGen, Inc. Pharmaceuticals
$73
Biofrontera Inc.
$70
Mayne Pharma Inc.
$69
DERMIRA, INC.
$60
Helsinn Therapeutics (U.S.), Inc.
$55
Boehringer Ingelheim Pharmaceuticals, Inc.
$54
Genentech USA, Inc.
$42
Pierre Fabre Pharmaceuticals, Inc.
$36
Arcutis Biotherapeutics, Inc.
$33
Promius Pharma LLC
$26
Verrica Pharmaceuticals Inc.
$24
Kyowa Kirin, Inc.
$20
Allergan, Inc.
$20
VYNE Pharmaceuticals Inc.
$17
Aclaris Therapeutics, Inc.
$17
Top 3 companies account for 25.4% of all-time payments
Associated products mentioned in payments ›
ADBRY · AKLIEF · ALTRENO · AMELUZ · AMZEEQ · Absorica LD · Aczone · BIAFINE · BLU-U · BOTOX · BRYHALI · Bimzelx · CIBINQO · CLODERM · COSENTYX · Cabtreo · Cimzia · Cordran · DERMATITIS - DISEASE · DORYX · DUPIXENT · DYSPORT · ENSTILAR · EPSOLAY · EUCRISA · Enbrel · Erivedge · HUMIRA · Humira · ILUMYA · Ilumya · KYBELLA · Klisyri · LITFULO · OLUMIANT · ONEXTON · OPZELURA · ORACEA · Odomzo · Otezla · PICATO · POTELIGEO · QBREXZA · REMICADE · RHOFADE · RINVOQ · SILIQ · SKYRIZI · SOOLANTRA · SPEVIGO · SPRYCEL · Seysara · Sitavig · Sotyktu · TALTZ · TREMFYA · TWYNEO · Trianex · VALCHLOR · VTAMA · Veltin · Xeomin · Xolair · YCANTH
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Dermatologists in nearby ZIP areas
3
County median income
$58,082
Nearest hospital to ZIP centroid (approximate)
UNC HEALTH CARE WAYNE
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Trakimas is a clinical cardiology specialist, with moderate Medicare volume, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Trakimas experienced with destruction of precancerous skin growths, 2-14?
Based on Medicare claims data, Dr. Trakimas performed 967 destruction of precancerous skin growths, 2-14 services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Trakimas receive payments from pharmaceutical companies?
Yes. Dr. Trakimas received a total of $10,847 from 41 companies across 496 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Trakimas's costs compare to other dermatologists in Goldsboro?
Dr. Trakimas's average Medicare payment per service is $38. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Trakimas) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Dermatologists in Goldsboro
Browse dermatologists in Goldsboro ranked by procedure volume and transparency data.
Highest volume
Top Dermatologists in NC
Dermatologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Dermatologists in NC
Which NC dermatologists receive the most from drug and device companies.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
AbbVie Inc. Payments to Doctors
See all physicians who received payments from AbbVie Inc.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology